Inceptionr LLC Buys New Stake in National Health Investors, Inc. $NHI

Inceptionr LLC purchased a new position in National Health Investors, Inc. (NYSE:NHI) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 5,335 shares of the real estate investment trust’s stock, valued at approximately $374,000.

A number of other hedge funds also recently bought and sold shares of NHI. JPMorgan Chase & Co. grew its stake in shares of National Health Investors by 305.2% in the 2nd quarter. JPMorgan Chase & Co. now owns 1,203,492 shares of the real estate investment trust’s stock worth $84,389,000 after buying an additional 906,479 shares in the last quarter. MetLife Investment Management LLC lifted its holdings in shares of National Health Investors by 706.6% in the 1st quarter. MetLife Investment Management LLC now owns 213,730 shares of the real estate investment trust’s stock valued at $15,786,000 after acquiring an additional 187,233 shares during the last quarter. Bowen Hanes & Co. Inc. purchased a new position in National Health Investors in the first quarter worth about $10,340,000. Nuveen LLC bought a new stake in National Health Investors during the first quarter worth approximately $10,126,000. Finally, Centersquare Investment Management LLC increased its position in shares of National Health Investors by 25.7% during the 1st quarter. Centersquare Investment Management LLC now owns 495,971 shares of the real estate investment trust’s stock valued at $36,632,000 after purchasing an additional 101,538 shares during the last quarter. Hedge funds and other institutional investors own 62.51% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently commented on NHI. Weiss Ratings reiterated a “buy (b-)” rating on shares of National Health Investors in a report on Wednesday, October 8th. National Bankshares set a $90.00 price objective on National Health Investors in a report on Wednesday, October 1st. Cantor Fitzgerald began coverage on National Health Investors in a research note on Wednesday, October 1st. They issued an “overweight” rating and a $90.00 target price on the stock. Truist Financial boosted their target price on shares of National Health Investors from $77.00 to $81.00 and gave the company a “buy” rating in a research note on Friday, August 15th. Finally, Wells Fargo & Company raised their price target on shares of National Health Investors from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Tuesday. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, National Health Investors has an average rating of “Buy” and an average target price of $85.67.

National Health Investors Price Performance

Shares of NHI stock opened at $79.48 on Friday. National Health Investors, Inc. has a twelve month low of $65.13 and a twelve month high of $80.56. The company has a current ratio of 10.91, a quick ratio of 10.91 and a debt-to-equity ratio of 0.75. The stock has a fifty day simple moving average of $76.74 and a two-hundred day simple moving average of $74.62. The stock has a market capitalization of $3.79 billion, a price-to-earnings ratio of 25.39, a P/E/G ratio of 3.31 and a beta of 0.74.

National Health Investors (NYSE:NHI) last released its quarterly earnings data on Thursday, November 6th. The real estate investment trust reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.08. National Health Investors had a return on equity of 10.32% and a net margin of 40.97%.The firm had revenue of $83.36 million during the quarter, compared to the consensus estimate of $85.66 million. During the same period in the previous year, the company posted $1.03 earnings per share. The firm’s quarterly revenue was down 1.8% on a year-over-year basis. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. On average, analysts predict that National Health Investors, Inc. will post 4.41 EPS for the current fiscal year.

National Health Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st will be paid a dividend of $0.92 per share. The ex-dividend date is Wednesday, December 31st. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.6%. National Health Investors’s dividend payout ratio (DPR) is currently 116.09%.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.